Essential Reads: Breastfeeding and ADHD Medications
Many women taking stimulants question whether it is safe to take these medications while breastfeeding. Â
SSRIs, SNRIs, and Pregnancy: Reassuring Data on Neurodevelopmental Outcomes
A large meta-analysis finds no causal link between prenatal antidepressant exposure and neurodevelopmental disorders after accounting for confounding factors.
Isn’t It Time for Stricter Valproic Acid Warnings for Women of Reproductive Age?
Despite FDA warnings, valproate is still prescribed to women of reproductive age, placing children at risk for birth defects and neurodevelopmental disorders.
Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring
Prenatal exposure to valproate is linked to increased risk of autism spectrum disorder, ADHD, lower IQ, and intellectual disability, especially at higher doses.
Patterns of ADHD Medication Usage During Pregnancy and the Postpartum Period
In women with ADHD, about 60% of women with ADHD elect to discontinue ADHD medications around the time of conception.
You Asked: In a Woman with ADHD, Should You Continue Treatment with a Stimulant During the Postpartum Period?
A growing body of literature supports the reproductive safety of stimulants in pregnant women and suggests that not treating may have negative consequences for the mother and her child.
In Women with ADHD, Should We Adjust Stimulant Dosage Premenstrually?
This preliminary study demonstrates the potential benefits of increasing the dosage of psychostimulant medication premenstrually in women with ADHD who experience premenstrual worsening of ADHD and mood symptoms.
Allison Baker, MD on the Specialized Care of Pregnant and Postpartum Women with ADHD
To better care for pregnant and postpartum mothers with ADHD, clinicians should understand the unique facets of ADHD in women, how symptoms change during pregnancy and the postpartum period, and how to help new parents make decisions around medication use and ADHD symptom management.
Neurodevelopmental Outcomes in Children with Exposure to Prescription Stimulants During Pregnancy
Prenatal exposure to prescription stimulants was not associated with an increased risk of neurodevelopmental disorders in exposed children.
Essential Reads: Modafinil and Armodafinil During Pregnancy Associated with Increased Risk of Malformations
Modafinil (brand name Provigil) and armodafinil (Nuvigil) are wake-promoting agents used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea. They are also used in other settings, often in [...]